SunOpta (STKL)
(Delayed Data from NSDQ)
$5.48 USD
-0.02 (-0.36%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $5.48 0.00 (0.00%) 5:52 PM ET
3-Hold of 5 3
B Value A Growth A Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
STKL 5.48 -0.02(-0.36%)
Will STKL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for STKL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for STKL
BellRing Brands (BRBR) Q3 Earnings and Revenues Top Estimates
Chefs' Warehouse (CHEF) Beats Q2 Earnings and Revenue Estimates
STKL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zacks.com featured highlights Catalyst Pharmaceuticals, SunOpta, Gambling.com and Orion Group
Rising Cash Flows Make These 4 Stocks Worth Choosing Now
All You Need to Know About SunOpta (STKL) Rating Upgrade to Strong Buy
Other News for STKL
Tracking Leon Cooperman's Omega Advisors Portfolio - Q1 2025 Update
SunOpta CEO Makes Bold Move with Major Stock Purchase
Embark Small Cap Equity Fund Q1 2025 Commentary
SunOpta: This Plunge Offers A Buying Opportunity (Rating Upgrade)
Adecoagro Trades Cheap, But Lacks Near-Term Catalysts